This is the second of three episodes of “Innovation and Protection: The Future of Medical Device Regulation,” a podcast miniseries created to replace the 2020 Petrie-Flom Center Annual Conference in light of the COVID-19 pandemic.
The COVID-19 pandemic has underscored the importance of the biosciences in our world, as well as the legal, ethical, and regulatory choices that shape the development and implementation of innovations from the biosciences.
The Journal of Law and the Biosciences (JLB) offers high-quality, open-access scholarship at the intersection of the biosciences and law as the first fully open-access, peer-reviewed, legal journal to focus on these issues.
Recently, the Journal of Law and the Biosciences received an updated impact factor of 2.275, highlighting its relevance and influence in law, medicine, and ethics. JLB ranks 25th out of 154 law journals, second of sixteen legal medicine journals, and third out of sixteen medical ethics journals.
By Jorge L. Contreras, JD
The U.S. patent system gives inventors a 20-year exclusive right to their inventions to incentivize the creation of new technologies.
But what if you have a great idea for a new technology, but never actually create it, test it, or determine that it works? Is that patentable? Conversely, should the U.S. Patent and Trademark Office (PTO) grant patents covering imaginary, fraudulent and otherwise non-existent inventions? Probably not, but it happens with alarming frequency, and it is causing serious problems.
Bill of Health strongly affirms that black lives and black voices matter, and we want to do more to feature and amplify the work of BIPOC scholars and students.
Accordingly, we are looking for new, regular contributors to Bill of Health, as well as guest bloggers. Regular contributors generally publish between five and 12 posts per year. Guest bloggers typically contribute two to five posts over the course of a one-month period. We welcome news, commentary, and scholarship in the fields of health law policy, biotechnology, and bioethics. Posts are typically 750 words in length.
If you are interested in becoming a regular contributor or guest blogger, please email editor-in-chief Chloe Reichel.
On March 24, 2020, the Journal of Law and the Biosciences, jointly run by Duke University, Harvard University Law School, and Stanford University, put out a call for essays and articles on governance in a time of pandemic. Between April 22 and May 28, it published 25 articles, all of which are available at the Journal’s website free of charge. We expect that more than 20 additional pieces will join them over the next month or so. The following is a regularly updated list, organized by date and time of publication, of what has been published in that special issue to date.
By James W. Lytle
After a banner year for organ transplantation in the United States in 2019, the success became a tattered memory by April 2020, when the COVID-19 pandemic hit major cities in the U.S. with its full fury.
A record number of 39,178 organs were donated in 2019, including 7,397 organs from living donors, also an all-time high. After several years of adverse media and regulatory scrutiny, LiveOn NY, the organ procurement organization (OPO) that serves the Metropolitan New York City region, proudly reported that a total of 938 organs had been transplanted in 2019, another record that represented more than a fifty percent increase over the transplant total in 2015.
By late April 2020, however, organ transplantation activity in New York State had reportedly declined by ninety percent.
In response to the COVID-19 pandemic, companies, organizations, and individuals have sought to address supply chain gaps for needed medical equipment. Spare parts and products created during the COVID-19 pandemic include ventilator tube splitters, nasopharyngeal swabs, and face shields.
In the past, outside of the context of a public health crisis, I have discussed the need to adopt legislation to create a narrow exemption from design patent liability to assure a competitive supply of automobile repair parts. The current pandemic makes a stronger case for the need to explicitly incorporate into our legal system a right to repair and supply products in emergencies.
In this virtual issue from Journal of Law and the Biosciences, we present 17 informative articles, published in 2017-2019, hand-picked by the journal’s three Editors-in-Chief: Nita Farahany from Duke University, Hank Greely from Stanford University, and Glenn Cohen from Harvard Law School.
This specially curated article collection examines a range of matters focusing on the intersection of law and the biosciences, including whether a complete ban on surrogacy is compatible with the American Convention on Human Rights, what role should law play when genetic privacy is concerned, or what opportunities and challenges there are for forensic psychiatry regarding brain-based mind reading.
In selecting articles for this virtual issue, the Editorial Board aims to emphasize the high-quality studies published in Journal of Law and the Biosciences and hopes these will stimulate further research in this new important field.
By Adriana Krasniansky
In many medical circumstances, clinicians and caregivers may choose not to leave a patient alone. For example, a patient may present a fall risk, experience confusion and agitation, or be at risk of self-harm. Traditionally, in such situations, a hospital assigns the patient a sitter, or a caregiver who provides patients patient supervision and companionship.
The need for sitters in hospital settings is rising, as patient loads increase and fewer patients have family members who are able to stay with them for long periods of time. Sitters are also a considerable investment for hospitals; one community hospital reported employing 14 sitters a day, totaling $425,000 in costs annually. Many healthcare networks are exploring the possibility of TeleSitters, or virtual monitoring systems to support patient care. In this article, we review the national adoption of TeleSitters and point out benefits and considerations to their implementation. Read More